Arbutus Biopharma CorporationArbutus Biopharma CorporationArbutus Biopharma Corporation

Arbutus Biopharma Corporation

No trades
See on Supercharts

Price target

5.000.000.00%
The 5 analysts offering 1 year price forecasts for ABUS have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to ABUS in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ABUS EPS for the last quarter is −0.11 USD despite the estimation of −0.10 USD. In the next quarter EPS is expected to reach −0.09 USD. Track more of Arbutus Biopharma Corporation financials and stay on top of what is up with the company.
In the next quarter Arbutus Biopharma Corporation revenue is expected to reach ‪1.86 M‬ USD. Check out Arbutus Biopharma Corporation revenue and earnings and make informed decisions.
According to analysts, ABUS price target is 5.00 USD with a max estimate of 7.00 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch Arbutus Biopharma Corporation stock price chart and keep track of the current situation with ABUS news and stock market news.
We've gathered opinions of 5 analysts rating ABUS stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.